News Column

France Biotech Announces the Public Companies and Partners to Attend

May 27, 2014

“FRENCH LIFE SCIENCES DAYS” in New-York on June 25 & 26, 2014

PARIS--(BUSINESS WIRE)-- France Biotech, an association of entrepreneurs in the life sciences industry, today announced the companies and partners who will participate in the first annual “French Life Sciences Days,” a major event that will bring together French biotech and medtech companies listed on the NYSE Euronext exchange and members of the North American financial community.

Prominent partners with various expertise of importance to the life sciences industry will also be joining the event, which will be held at the W New York Hotel on June 25th and 26th. Among the partners are investment banks – SociÉtÉ GÉnÉrale, Bryan Garnier & Co., and Invest Security; Deloitte, one of the world’s largest audit and advisory firms; NewCap, an investor relations and financial communications agency; and BusinessWire, a leader in press release distribution and regulatory disclosure.

The 19 listed companies recognized for their breakthrough innovations, achievements and international exposure that will be present and engage in dialogue with U.S. investment funds are:

1. Carmat (Alternext : ALCAR, FR0010907956)

2. Crossject (Euronext Paris : ALCJ, FR0011716265)

3. Diaxonhit (Alternext : ALEHT, FR0004054427)

4. DBV Technologies (Euronext Paris : DBV, FR0010417345)

5. EOS imaging (Euronext Paris : EOSI, FR0011191766)

6. Erytech Pharma (Euronext Paris : ERYP, FR0011471135)

7. Genticel (Euronext Paris & Bruxelles : GTCL, FR0011790542)

8. Genomic Vision (Euronext Paris : GV, FR0011799907)

9. Hybrigenics (Alternext : ALHYG, FR0004153930)

10. Implanet (Euronext : IMPL, FR0010458729)

11. Mauna Kea Technologies (Euronext: MKEA, FR0010609263)

12. Neovacs (Alternext Paris : ALNEV, FR0004032746)

13. Olmix (Euronext marchÉ libre: MLOLM)

14. Quantum Genomics (Alternext : ALQGC, FR0011648971)

15. Stentys (Euronext Paris: STNT, FR0010949404)

16. TxCell (Euronext Paris : TXCL, FR0010127662)

17. Theraclion (Alternext : ALTHE, FR0010120402)

18. Theradiag (Alternext : ALTER, FR0004197747)

19. Transgene (Euronext Paris: TNG, FR0005175080)

“19 potential world champions will represent France’s life-sciences industry to an audience of specialized American investors! We are delighted by the high level of interest evidenced for “French Life Sciences Days,” which will take place for the first time in New York with the U.S. financial community. This event will be an important opportunity and milestone event for France. In our industry, finance is the friend of innovation and employment. Our companies were born with an international dimension, and they develop breakthrough innovations that are increasingly attractive to foreign investors. The life sciences sector is the future of the pharmaceutical industry, which is increasingly turning to these innovations. It is a promising sector, whose strong growth worldwide offers a pool of opportunity for highly-skilled French workers. We thank the 19 companies and our partners (Bryan Garnier & Co., SociÉtÉ GÉnÉrale, Invest Security, Deloitte and NewCap) who will participate in the event. This first edition is intended to be replicated in countries where it will be important for our companies to showcase their innovations and breakthroughs,” explains Pierre-Olivier GOINEAU, the president of France Biotech.

About France Biotech

France Biotech brings together the main French life science companies and their expert partners. Its mission is to support the development of the French life sciences by advocating for a favorable regulatory and fiscal environment. The organization is currently chaired by Pierre-Olivier Goineau, CEO of ERYTECH Pharma, and has over 150 members and its board of directors is composed of 20 entrepreneurs.

France Biotech

Haude Costa, Tel : +33-156-58-10-70 / 06-84-25-88-27


Press contact:

Rooney & Associates

Marion Janic, Tel: +1-212.223.4017

Source: France Biotech

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Business Wire

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters